Six Tech Stocks That Could Double

From Investorplace Media | Ad

5G… blockchain… electric vehicles… There are enough tech opportunities out there to make your head spin! But which ones should you own for the coming tech boom?

Louis Navellier — the analyst who found Microsoft at .38 cents — just released a new report detailing six tech stocks to own today.

Don’t miss your chance to get his latest picks — ticker symbol and all — completely free of charge.

Click here to get your free report today.

CRL Insider Trading (Charles River Laboratories International)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.20%

Insider Buying (Last 12 Months): $267,904.00

Insider Selling (Last 12 Months): $49,251,105.92

Charles River Laboratories International Insider Trading History Chart

Charles River Laboratories International Share Price & Price History

^$366.78

▼ -0.17 (-0.05%)

As of 06/24/2021 05:32 PM ET

Days: 30 | 90 | 365

Man who Picked Bitcoin at $428 Says "Buy Genesis"

From Legacy Research | Ad

He Picked Bitcoin (And Dogecoin) in 2016. What He's Recommending Now Could Turn Heads...

Watch more here!

Charles River Laboratories International Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/3/2021	Michael Gunnar Knell	CAO	Sell	800	$329.76	$263,808.00	4,563
6/1/2021	James C Foster	CEO	Sell	9,577	$332.23	$3,181,766.71	224,376
5/11/2021	George Massaro	Director	Sell	371	$320.06	$118,742.26	5,696
5/7/2021	James C Foster	CEO	Sell	7,500	$343.17	$2,573,775.00	221,088
5/6/2021	George Massaro	Director	Sell	3,370	$336.96	$1,135,555.20	7,169
5/4/2021	David Ross Smith	CFO	Sell	3,305	$340.01	$1,123,733.05	18,167
4/22/2021	David Ross Smith	CFO	Sell	3,845	$330.00	$1,268,850.00	18,707
4/15/2021	David Ross Smith	CFO	Sell	2,000	$320.00	$640,000.00	14,862
4/6/2021	Birgit Girshick	VP	Sell	18,311	$302.61	$5,541,091.71	30,059
2/25/2021	Joseph W Laplume	EVP	Sell	8,735	$281.70	$2,460,649.50
2/23/2021	James C Foster	CEO	Sell	37,731	$281.27	$10,612,598.37	221,151
2/19/2021	Birgit Girshick	VP	Sell	1,675	$293.92	$492,316.00	31,680
2/19/2021	David Ross Smith	CFO	Sell	8,656	$290.63	$2,515,693.28	17,303
2/19/2021	Michael Gunnar Knell	CAO	Sell	410	$290.99	$119,305.90	4,198
2/11/2021	James C Foster	CEO	Sell	30,000	$285.02	$8,550,600.00	255,041
11/4/2020	Joseph W Laplume	EVP	Sell	6,739	$250.28	$1,686,636.92
11/3/2020	William D Barbo	VP	Sell	2,150	$236.29	$508,023.50	5,899
11/2/2020	James C Foster	CEO	Sell	22,000	$232.38	$5,112,360.00	209,777
11/2/2020	Richard F Wallman	Director	Buy	1,150	$232.96	$267,904.00	31,715
9/14/2020	George Massaro	Director	Sell	1,943	$219.91	$427,285.13	11,384
8/20/2020	Birgit Girshick	VP	Sell	933	$213.51	$199,204.83	22,852
8/18/2020	Stephen D Chubb	Director	Sell	1,000	$217.65	$217,650.00
8/7/2020	Deborah Turner Kochevar	Director	Sell	2,319	$216.24	$501,460.56	6,728
5/22/2020	George Massaro	Director	Sell	941	$173.40	$163,169.40	12,222
5/20/2020	Robert J Bertolini	Director	Sell	3,530	$174.58	$616,267.40	32,664
5/12/2020	Birgit Girshick	VP	Sell	780	$165.74	$129,277.20	21,837
5/11/2020	James C. Foster	CEO	Sell	17,446	$162.53	$2,835,498.38
2/24/2020	David Ross Smith	CFO	Sell	8,211	$166.72	$1,368,937.92	25,219
2/24/2020	James C Foster	CEO	Sell	44,303	$166.70	$7,385,310.10	313,054
2/13/2020	David Ross Smith	CFO	Sell	4,500	$170.29	$766,305.00	21,978
2/13/2020	Robert J Bertolini	Director	Sell	7,170	$170.41	$1,221,839.70	31,905
2/13/2020	William D Barbo	VP	Sell	6,901	$172.11	$1,187,731.11	18,931
12/9/2019	Birgit Girshick	VP	Sell	1,051	$145.55	$152,973.05	18,728
11/13/2019	Birgit Girshick	VP	Sell	1,499	$137.23	$205,707.77	25,459
8/12/2019	David Ross Smith	Insider	Sell	1,249	$130.36	$162,819.64	19,327
5/29/2019	William D Barbo	Insider	Sell	4,905	$125.16	$613,909.80	25,859
5/15/2019	George Massaro	Director	Sell	1,002	$131.38	$131,642.76	11,204
5/10/2019	George Massaro	Director	Sell	3,140	$134.64	$422,769.60	15,344
3/8/2019	Joseph W Laplume	EVP	Sell	5,522	$137.61	$759,882.42	16,325
2/27/2019	David Ross Smith	Insider	Sell	2,158	$141.07	$304,429.06	20,573
2/27/2019	James C Foster	Chairman	Sell	513	$142.49	$73,097.37	300,777
2/27/2019	William D Barbo	VP	Sell	8,155	$141.03	$1,150,099.65	31,756
2/25/2019	David Ross Smith	CFO	Sell	4,000	$145.43	$581,720.00	24,262
2/25/2019	James C Foster	CEO	Sell	3,000	$146.02	$438,060.00	286,397
2/22/2019	George M Milne Jr	Director	Sell	4,540	$143.00	$649,220.00	28,883
2/19/2019	Stephen D Chubb	Director	Sell	4,540	$141.23	$641,184.20	38,868
1/8/2019	James C. Foster	Chairman	Sell	25,000	$115.00	$2,875,000.00
12/10/2018	James C Foster	Chairman	Sell	1,977	$129.11	$255,250.47	267,676
12/4/2018	Robert J Bertolini	Director	Sell	3,440	$133.77	$460,168.80	29,876
11/12/2018	David Ross Smith	Insider	Sell	1,866	$134.49	$250,958.34	12,341
11/7/2018	David P Johst	Insider	Sell	23,356	$136.00	$3,176,416.00	219,849
9/4/2018	Deborah Turner Kochevar	Director	Sell	4,066	$123.66	$502,801.56	10,190
8/13/2018	David Ross Smith	Insider	Sell	1,249	$120.05	$149,942.45	13,690
7/23/2018	Davide Molho	COO	Sell	11,600	$125.00	$1,450,000.00	22,079
7/17/2018	Birgit Girshick	Insider	Sell	3,978	$119.90	$476,962.20	18,999
7/17/2018	Davide Molho	COO	Sell	11,126	$120.00	$1,335,120.00	44,805
7/2/2018	James C Foster	CEO	Sell	5,005	$110.80	$554,554.00	296,676
6/25/2018	George Massaro	Director	Sell	300	$115.55	$34,665.00	14,037

Insider Buying at Charles River Laboratories International?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Charles River Laboratories International and related companies.

SEC Filings (Institutional Ownership Changes) for Charles River Laboratories International (NYSE:CRL)

93.87% of Charles River Laboratories International stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Charles River Laboratories International Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/17/2021	Geneos Wealth Management Inc.	699	$0.23M	0.0%	+10.3%	0.001%
6/2/2021	Intrust Bank NA	3,135	$0.91M	0.1%	+4.3%	0.006%
5/29/2021	Rehmann Capital Advisory Group	750	$0.22M	0.0%	-15.6%	0.001%
5/28/2021	Schroder Investment Management Group	19,876	$5.76M	0.0%	-11.5%	0.040%
5/27/2021	Jackson Creek Investment Advisors LLC	1,002	$0.29M	0.1%	N/A	0.002%
5/27/2021	Fragasso Group Inc.	22,861	$6.63M	0.9%	+1.2%	0.045%
5/25/2021	Regency Capital Management Inc. DE	5,136	$1.49M	1.6%	N/A	0.010%
5/24/2021	Principal Financial Group Inc.	173,768	$50.36M	0.0%	+15.9%	0.346%
5/22/2021	Teachers Retirement System of The State of Kentucky	7,260	$2.10M	0.0%	-8.8%	0.014%
5/19/2021	Baker Tilly Wealth Management LLC	1,256	$0.36M	0.1%	+22.2%	0.002%
5/19/2021	Virtu Financial LLC	2,030	$0.59M	0.0%	+48.9%	0.004%
5/19/2021	TownSquare Capital LLC	7,627	$2.21M	0.1%	+16.2%	0.015%
5/19/2021	Squarepoint Ops LLC	5,200	$1.51M	0.0%	-89.2%	0.010%
5/18/2021	Earnest Partners LLC	220,051	$63.78M	0.4%	-17.3%	0.438%
5/18/2021	Paloma Partners Management Co	11,670	$3.38M	0.1%	+925.5%	0.023%
5/18/2021	Oppenheimer Asset Management Inc.	27,798	$8.06M	0.1%	+67.4%	0.055%
5/18/2021	Utah Retirement Systems	9,415	$2.73M	0.0%	-3.7%	0.019%
5/18/2021	Point72 Asset Management L.P.	154,022	$44.64M	0.2%	+119.2%	0.306%
5/18/2021	Eaton Vance Management	253	$73K	0.0%	N/A	0.001%
5/18/2021	Amundi Asset Management US Inc.	114,950	$33.32M	0.0%	+9.8%	0.229%
5/18/2021	Leuthold Group LLC	1,428	$0.41M	0.1%	-2.4%	0.003%
5/18/2021	Loomis Sayles & Co. L P	113,296	$32.84M	0.0%	+0.1%	0.225%
5/18/2021	State of Wisconsin Investment Board	6,196	$1.80M	0.0%	-1.5%	0.012%
5/18/2021	Morgan Stanley	167,712	$48.61M	0.0%	-10.0%	0.334%
5/18/2021	Maverick Capital Ltd.	4,899	$1.42M	0.0%	N/A	0.010%
5/18/2021	Tudor Investment Corp Et Al	13,786	$4M	0.1%	+55.7%	0.027%
5/18/2021	Sandler Capital Management	198,321	$57.48M	4.9%	+5.5%	0.395%
5/18/2021	Redmile Group LLC	166,679	$48.31M	0.7%	N/A	0.332%
5/18/2021	Cubist Systematic Strategies LLC	11,688	$3.39M	0.0%	+205.7%	0.023%
5/18/2021	Glenmede Trust Co. NA	831	$0.24M	0.0%	-11.4%	0.002%
5/18/2021	FORA Capital LLC	718	$0.21M	0.1%	-48.9%	0.001%
5/18/2021	Gotham Asset Management LLC	3,537	$1.03M	0.0%	-49.4%	0.007%
5/18/2021	Man Group plc	23,489	$6.81M	0.0%	-58.6%	0.047%
5/18/2021	California State Teachers Retirement System	87,273	$25.29M	0.0%	-0.5%	0.174%
5/18/2021	Ameritas Investment Company LLC	2,888	$0.84M	0.1%	N/A	0.006%
5/18/2021	Wealth Alliance	1,536	$0.45M	0.1%	+5.9%	0.003%
5/17/2021	Viking Global Investors LP	448,716	$130.05M	0.4%	N/A	0.893%
5/17/2021	Schonfeld Strategic Advisors LLC	6,094	$1.77M	0.0%	+63.6%	0.012%
5/17/2021	PDT Partners LLC	1,400	$0.41M	0.0%	N/A	0.003%
5/17/2021	Fred Alger Management LLC	88	$26K	0.0%	N/A	0.000%
5/17/2021	Great West Life Assurance Co. Can	19,567	$5.66M	0.0%	-23.5%	0.039%
5/17/2021	AQR Capital Management LLC	170,683	$49.47M	0.1%	-33.2%	0.340%
5/17/2021	Royal Bank of Canada	719,745	$208.60M	0.1%	+3.4%	1.432%
5/17/2021	Veritable L.P.	754	$0.22M	0.0%	N/A	0.002%
5/17/2021	Price T Rowe Associates Inc. MD	247,223	$71.65M	0.0%	-7.4%	0.492%
5/17/2021	Woodline Partners LP	31,736	$9.20M	0.2%	+21.1%	0.063%
5/17/2021	Marks Group Wealth Management Inc	3,345	$0.98M	0.1%	+2.0%	0.007%
5/17/2021	Captrust Financial Advisors	3,484	$1.01M	0.0%	+95.0%	0.007%
5/17/2021	Clark Capital Management Group Inc.	107,331	$31.11M	0.5%	-9.7%	0.214%
5/17/2021	Redwood Investments LLC	15,790	$4.58M	0.4%	+34.0%	0.031%
5/17/2021	Ameriprise Financial Inc.	908,505	$263.31M	0.1%	-21.0%	1.808%
5/17/2021	Nomura Holdings Inc.	6,750	$1.96M	0.0%	N/A	0.013%
5/17/2021	HRT Financial LP	58,879	$17.06M	0.2%	+3.5%	0.117%
5/17/2021	Aristotle Capital Boston LLC	325,682	$94.39M	2.1%	-8.5%	0.648%
5/17/2021	Mirabella Financial Services LLP	29,027	$8.41M	2.6%	+32.6%	0.058%
5/17/2021	Lakewood Capital Management LP	163,000	$47.24M	2.0%	-7.9%	0.324%
5/17/2021	Nuveen Asset Management LLC	260,524	$75.51M	0.0%	-1.7%	0.518%
5/17/2021	Gilder Gagnon Howe & Co. LLC	25,351	$7.35M	0.0%	+0.2%	0.050%
5/17/2021	Kayne Anderson Rudnick Investment Management LLC	1,261,319	$365.57M	1.0%	+15.5%	2.510%
5/17/2021	Nordea Investment Management AB	38,103	$11.14M	0.0%	+3.8%	0.076%
5/17/2021	Tower House Partners LLP	157,241	$45.57M	22.2%	-16.0%	0.313%
5/17/2021	Thrivent Financial for Lutherans	62,699	$18.17M	0.0%	-5.3%	0.125%
5/17/2021	Goldman Sachs Group Inc.	195,091	$56.54M	0.0%	+27.0%	0.388%
5/14/2021	Sculptor Capital LP	79,658	$23.09M	0.2%	-55.5%	0.159%
5/14/2021	Ontario Teachers Pension Plan Board	693	$0.20M	0.0%	-70.4%	0.001%
5/14/2021	Brown Advisory Inc.	881,648	$255.53M	0.4%	+2.9%	1.754%
5/14/2021	Profund Advisors LLC	11,448	$3.32M	0.1%	-17.6%	0.023%
5/14/2021	Paradigm Financial Partners LLC	1,826	$0.53M	0.1%	+22.4%	0.004%
5/14/2021	MML Investors Services LLC	3,643	$1.06M	0.0%	+47.2%	0.007%
5/14/2021	Picton Mahoney Asset Management	28,490	$8.26M	0.4%	-3.6%	0.057%
5/14/2021	Gabelli Funds LLC	22,111	$6.41M	0.0%	-24.0%	0.044%
5/14/2021	Kennedy Capital Management Inc.	28,616	$8.29M	0.2%	-12.5%	0.057%
5/14/2021	Eqis Capital Management Inc.	2,178	$0.63M	0.0%	-21.5%	0.004%
5/14/2021	Cambiar Investors LLC	22,661	$6.57M	0.2%	+14.8%	0.045%
5/14/2021	Johnson Investment Counsel Inc.	17,006	$4.93M	0.1%	+20.7%	0.034%
5/14/2021	Public Employees Retirement System of Ohio	27,045	$7.84M	0.0%	+9.9%	0.054%
5/14/2021	Lazard Asset Management LLC	131,315	$38.06M	0.0%	-16.2%	0.261%
5/14/2021	FIL Ltd	511,933	$148.37M	0.2%	-36.9%	1.019%
5/14/2021	Dimensional Fund Advisors LP	420,453	$121.86M	0.0%	-2.7%	0.837%
5/14/2021	Flputnam Investment Management Co.	97,579	$28.28M	1.2%	-2.6%	0.194%
5/14/2021	Tekla Capital Management LLC	43,074	$12.48M	0.4%	+53.0%	0.086%
5/14/2021	Parkman Healthcare Partners LLC	50,000	$14.49M	3.4%	+26.1%	0.099%
5/14/2021	XTX Topco Ltd	1,009	$0.29M	0.1%	N/A	0.002%
5/14/2021	CIBC Asset Management Inc	1,832	$0.53M	0.0%	-5.2%	0.004%
5/14/2021	Wealthfront Advisers LLC	847	$0.25M	0.0%	N/A	0.002%
5/14/2021	Logan Capital Management Inc.	19,730	$5.72M	0.3%	+8.0%	0.039%
5/14/2021	Algert Global LLC	1,412	$0.41M	0.1%	N/A	0.003%
5/14/2021	TD Asset Management Inc.	37,242	$10.79M	0.0%	-56.6%	0.074%
5/14/2021	Nicholas Company Inc.	60,555	$17.55M	0.3%	-0.8%	0.121%
5/14/2021	C M Bidwell & Associates Ltd.	424	$0.12M	0.1%	N/A	0.001%
5/14/2021	Globeflex Capital L P	6,781	$1.97M	0.4%	+1.5%	0.013%
5/14/2021	UBS Asset Management Americas Inc.	81,217	$23.54M	0.0%	-11.4%	0.162%
5/14/2021	Stifel Financial Corp	72,076	$20.89M	0.0%	+6.0%	0.143%
5/14/2021	Credit Suisse AG	62,290	$18.05M	0.0%	-22.4%	0.124%
5/14/2021	Rothschild & Co. Asset Management US Inc.	64,947	$18.82M	0.2%	-28.2%	0.129%
5/14/2021	Primecap Management Co. CA	370,260	$107.31M	0.1%	0.0%	0.737%
5/13/2021	Clearbridge Investments LLC	288,128	$83.51M	0.1%	+27.4%	0.573%
5/13/2021	Bessemer Group Inc.	1,391	$0.40M	0.0%	-24.2%	0.003%
5/13/2021	Guggenheim Capital LLC	12,253	$3.55M	0.0%	+2.7%	0.024%
5/13/2021	Advantage Alpha Capital Partners LP	16,915	$4.90M	1.0%	-43.4%	0.034%

Data available starting January 2016

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains and purpose-bred rats and mice for use by researchers. It also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets and chemical compounds through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. It also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company was founded in 1947 and is based in Wilmington, Massachusetts.

Today's Range

Now: $366.78

$366.22

$370.58

50 Day Range

MA: $336.12

$316.76

$366.95

52 Week Range

Now: $366.78

$167.55

$370.58

Volume

306,113 shs

Average Volume

483,729 shs

Market Capitalization

$18.43 billion

P/E Ratio

49.70

Dividend Yield

N/A

Beta

1.14

Who are the company insiders with the largest holdings of Charles River Laboratories International?

Charles River Laboratories International's top insider investors include:

James C Foster (CEO)
Robert J Bertolini (Director)
Richard F Wallman (Director)
Birgit Girshick (VP)
David Ross Smith (CFO)
David Ross Smith (Insider)
William D Barbo (VP)
George Massaro (Director)
Deborah Turner Kochevar (Director)
Michael Gunnar Knell (CAO)
James C Foster (CEO)
Joseph W Laplume (EVP)
Stephen D Chubb (Director)

Who are the major institutional investors of Charles River Laboratories International?

Charles River Laboratories International's top institutional investors include:

BlackRock Inc. — 11.13%
Massachusetts Financial Services Co. MA — 2.74%
Kayne Anderson Rudnick Investment Management LLC — 2.51%
William Blair Investment Management LLC — 1.97%
Ameriprise Financial Inc. — 1.81%
Brown Advisory Inc. — 1.75%

Which major investors are selling Charles River Laboratories International stock?

During the last quarter, CRL stock was sold by these institutional investors:

FIL Ltd
Renaissance Technologies LLC
Ameriprise Financial Inc.
TimesSquare Capital Management LLC
Neuberger Berman Group LLC
Sculptor Capital LP
AQR Capital Management LLC
Acadian Asset Management LLC

In the last year, company insiders that have sold Charles River Laboratories International company stock include:

James C Foster (CEO)
Robert J Bertolini (Director)
Richard F Wallman (Director)
Birgit Girshick (VP)
David Ross Smith (CFO)
David Ross Smith (Insider)
William D Barbo (VP)
George Massaro (Director)
Deborah Turner Kochevar (Director)

Which major investors are buying Charles River Laboratories International stock?

During the previous quarter, CRL stock was bought by institutional investors including:

William Blair Investment Management LLC
Viking Global Investors LP
BlackRock Inc.
Kayne Anderson Rudnick Investment Management LLC
Redmile Group LLC
Riverbridge Partners LLC
Point72 Asset Management L.P.
JPMorgan Chase & Co.

L.O.C.K. System Says Buy These 5 Tech Stocks Now

From Empire Financial | Ad

L.O.C.K. called AMD at $2.67, Ring Central (RNG) at $20 and Square (SQ) at $11 -- Now it’s flashing GREEN on these five tech stocks.

Click Here Now!